Axa
WST icon

Axa’s West Pharmaceutical WST Stock Holding History

Axa’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,090
Closed -$457K – 1030
2025
Q2 		$457K Buy
2,090
+1,046
+100% +$224K ﹤0.01% 993
2025
Q1 		$234K Sell
1,044
-124
-11% -$34.2K ﹤0.01% 1009
2024
Q4 		$383K Buy
1,168
+94
+9% +$29.6K ﹤0.01% 966
2024
Q3 		$322K Sell
1,074
-16,875
-94% -$5.17M ﹤0.01% 1003
2024
Q2 		$5.91M Buy
17,949
+1,964
+12% +$694K 0.02% 497
2024
Q1 		$6.33M Sell
15,985
-6,657
-29% -$2.46M 0.02% 506
2023
Q4 		$7.97M Sell
22,642
-22,075
-49% -$7.81M 0.03% 444
2023
Q3 		$16.8M Sell
44,717
-20,077
-31% -$7.76M 0.06% 306
2023
Q2 		$24.8M Buy
64,794
+19,370
+43% +$6.92M 0.08% 250
2023
Q1 		$15.7M Sell
45,424
-99,871
-69% -$29.2M 0.05% 330
2022
Q4 		$34.2M Buy
145,295
+99,969
+221% +$23.7M 0.12% 200
2022
Q3 		$11.2M Sell
45,326
-72,706
-62% -$22.1M 0.04% 410
2022
Q2 		$35.7M Sell
118,032
-21,589
-15% -$7.02M 0.13% 178
2022
Q1 		$57.3M Sell
139,621
-21,689
-13% -$8.49M 0.16% 150
2021
Q4 		$75.7M Buy
161,310
+47,985
+42% +$20.7M 0.19% 124
2021
Q3 		$48.1M Sell
113,325
-67,553
-37% -$28.5M 0.14% 186
2021
Q2 		$65M Buy
180,878
+66,993
+59% +$22.1M 0.18% 136
2021
Q1 		$32.1M Sell
113,885
-7,953
-7% -$2.28M 0.1% 247
2020
Q4 		$34.5M Buy
121,838
+56,549
+87% +$15.9M 0.11% 217
2020
Q3 		$17.9M Sell
65,289
-35,799
-35% -$9.47M 0.06% 310
2020
Q2 		$23M Buy
101,088
+31,288
+45% +$6.15M 0.09% 245
2020
Q1 		$10.6M Buy
69,800
+54,900
+368% +$8.45M 0.05% 352
2019
Q4 		$2.24M Buy
+14,900
New +$2.17M 0.01% 788

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Axa's WST Position: Q3 2025 in Review

Axa sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 2,090 shares — an estimated $457K sold.

Axa first reported a position in WST in Q4 2019 and held it in 23 quarters. The position peaked at $75.7M in Q4 2021. 758 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Axa reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Axa sold 2,090 West Pharmaceutical shares in Q3 2025, an estimated $457K.
  • Axa first reported a position in West Pharmaceutical in Q4 2019 and held it in 23 quarters.
  • Axa's West Pharmaceutical position peaked at $75.7M in Q4 2021.
  • 758 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.